Clinical Trial Update: Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Linvemastat in patients with partially controlled asthma; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Linvemastat (Linvemastat)

Snippet

Sponsor: Foresee Pharmaceuticals Co., Ltd. | Conditions: Asthma (Diagnosis), Pulmonary Function | Phase 2 | Status: NOT_YET_RECRUITING